1. Home
  2. EDSA

as of 12-05-2025 4:00pm EST

$1.76
+$0.07
+4.14%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Chart Type:
Time Range:
Founded: 2015 Country:
Canada
Canada
Employees: N/A City: MARKHAM
Market Cap: 12.8M IPO Year: N/A
Target Price: $13.00 AVG Volume (30 days): 29.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.25 EPS Growth: N/A
52 Week Low/High: $1.55 - $4.49 Next Earning Date: 12-17-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered EDSA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 70.27%
70.27%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: